Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Barrx Medical, Inc.
Barrx Medical launches minimally invasive tool to treat Barrett esophagus
April 8th, 2006
Barrx Medical, Inc. introduced the HALO360 System, a new, minimally invasive tool for the treatment of Barrett's esophagus, a precancerous condition of the esophagus caused by gastroesophageal reflux disease (GERD). Left untreated, Barrett esophagus, which affects approximately three million U.S. adults, can lead to esophageal adenocarcinoma, the fastest rising cancer in the U.S. The HALO360 System is the first circumferential ablative tool that utilizes radiofrequency (RF) ablation therapy to remove the Barrett esophagus tissue before it progresses to cancer. The HALO360 System was designed, in part, to reduce the risk of complications that have been associated with...
Source: Law & Health Weekly (2006-04-08)
|
